Journal article

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates in 18–24-year-olds.

Languages

  • English

Publication year

2014

Journal

Vaccine

Volume

9960

Type

Journal article

Categories

  • Service delivery

Diseases

  • Meningococcal meningitis

Countries

  • United Kingdom Of Great Britain And Northern Ireland

Tags

  • New vaccine introduction

WHO Regions

  • European Region

Added by: Moderator

Added on: 2015-11-15 17:11:03

Hits: 888